Dr Ilaria Bernabei and the SULFISCON founders published this review which details the mechanisms leading to pathological calcification in cartilage and its role in osteoarthritis in Nature Reviews Rheumatology.
On the 5th July 2023, BIOPOLE announced that it has selected SULFISCON for its BIOPOLE STARTUP FUND award, worth 45k CHF in the first year. This will help SULFISCON develop its medicinal chemistry program and support its ongoing research